Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice

Chen, Xin; Liu, Bigang; Li, Qiuhui; Honorio, Sofia; Liu, Xin; Liu, Can; Multani, Asha S.; Calhoun-Davis, Tammy; Tang, Dean G.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Reconstitution of tumor development in immunodeficient mice from disaggregated primary human tumor cells is always challenging. The main goal of the present study is to establish a reliable assay system that would allow us to reproducibly reconstitute human prostate tumor regeneration in mice using patient tumor-derived single cells. Using many of the 114 untreated primary human prostate cancer (HPCa) samples we have worked on, here we show that: 1) the subcutaneum represents the most sensitive site that allows the grafting of the implanted HPCa pieces; 2) primary HPCa cells by themselves fail to regenerate tumors in immunodeficient hosts; 3) when coinjected in Matrigel with rUGM (rat urogenital sinus mesenchyme), CAF (carcinoma-associated fibroblasts), or Hs5 (immortalized bone marrow derived stromal) cells, primary HPCa cells fail to initiate serially transplantable tumors in NOD/SCID mice; and 4) however, HPCa cells coinjected with the Hs5 cells into more immunodeficient NOD/SCID-IL2Rγ−/− (NSG) mice readily regenerate serially transplantable tumors. The HPCa/Hs5 reconstituted ‘prostate’ tumors present an overall epithelial morphology, are of the human origin, and contain cells positive for AR, CK8, and racemase. Cytogenetic analysis provides further evidence for the presence of karyotypically abnormal HPCa cells in the HPCa/Hs5 tumors. Of importance, HPCa/Hs5 xenograft tumors contain EpCAM+ cells that are both clonogenic and tumorigenic. Surprisingly, all HPCa/Hs5 reconstituted tumors are undifferentiated, even for HPCa cells derived from Gleason 7 tumors. Our results indicate that primary HPCa cells coinjected with the immortalized Hs5 stromal cells generate undifferentiated tumors in NSG mice and we provide evidence that undifferentiated HPCa cells might be the cells that possessed tumorigenic potential and regenerated HPCa/Hs5 xenograft tumors.


Related Articles

  • RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis. Santos, Nuno R. dos; Williame, Maryvonne; Gachet, Stéphanie; Cormier, Françoise; Janin, Anne; Weih, Debra; Weih, Falk; Ghysdael, Jacques // PLoS ONE;2008, Vol. 3 Issue 7, p1 

    Background: The Rel/NF-κB transcription factors are often activated in solid or hematological malignancies. In most cases, NF-κB activation is found in malignant cells and results from activation of the canonical NF-κB pathway, leading to RelA and/or c-Rel activation. Recently, NF-κB...

  • Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer. Roca, Hernan; Hernandez, James; Weidner, Savannah; McEachin, Richard C.; Fuller, David; Sud, Sudha; Schumann, Taibriana; Wilkinson, John E.; Zaslavsky, Alexander; Li, Hangwen; Maher, Christopher A.; Daignault-Newton, Stephanie; Healy, Patrick N.; Pienta, Kenneth J. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Cell plasticity regulated by the balance between the mesenchymal to epithelial transition (MET) and the opposite program, EMT, is critical in the metastatic cascade. Several transcription factors (TFs) are known to regulate EMT, though the mechanisms of MET remain unclear. We demonstrate a novel...

  • Image-guided, Tumor Stroma-targeted 131I Therapy of Hepatocellular Cancer After Systemic Mesenchymal Stem Cell-mediated NIS Gene Delivery. Knoop, Kerstin; Kolokythas, Marie; Klutz, Kathrin; Willhauck, Michael J.; Wunderlich, Nathalie; Draganovici, Dan; Zach, Christian; Gildehaus, Franz-Josef; Böning, Guido; Göke, Burkhard; Wagner, Ernst; Nelson, Peter J.; Spitzweg, Christine // Molecular Therapy;Sep2011, Vol. 19 Issue 9, p1704 

    Due to its dual role as reporter and therapy gene, the sodium iodide symporter (NIS) allows noninvasive imaging of functional NIS expression by 123I-scintigraphy or 124I-PET imaging before the application of a therapeutic dose of 131I. NIS expression provides a novel mechanism for the evaluation...

  • Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Ting Zhang; Yuk Wai Lee; Yun Feng Rui; Tin Yan Cheng; Xiao Hua Jiang; Gang Li // Stem Cell Research & Therapy;2013, Vol. 4 Issue 3, p1 

    Introduction: Mesenchymal stem cells (MSCs) are known to migrate to tumor tissues. This behavior of MSCs has been exploited as a tumor-targeting strategy for cell-based cancer therapy. However, the effects of MSCs on tumor growth are controversial. This study was designed to determine the effect...

  • Interferon-{alpha} counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer. Persano, Luca; Moserle, Lidia; Esposito, Giovanni; Bronte, Vincenzo; Barbieri, Vito; Iafrate, Massimo; Gardiman, Marina P.; Larghero, Patrizia; Pfeffer, Ulrich; Naschberger, Elisabeth; Stürzl, Michael; Indraccolo, Stefano; Amadori, Alberto // Carcinogenesis;May2009, Vol. 30 Issue 5, p851 

    Interferon (IFN)-α is a cytokine with marked therapeutic activity in transplantable tumor models, that is in part due to angiogenesis inhibition. Aim of this study was to investigate the effects of IFN-α during the early phases of tumor development in the transgenic adenocarcinoma...

  • Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens. Yi, Huanfa; Yu, Xiaofei; Guo, Chunqing; Manjili, Masoud; Repasky, Elizabeth; Wang, Xiang-Yang // Cancer Immunology, Immunotherapy;Mar2011, Vol. 60 Issue 3, p349 

    In this study, we report a novel treatment strategy that could potentially be used to improve efficacy of adoptive cell therapy for patients with prostate cancer. We show that female C57BL/6 mice are able to effectively reject two syngeneic prostate tumors (TRAMP-C2 and RM1) in a T...

  • Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. Tuomela, Johanna M.; Valta, Maija P.; Väänänen, Kalervo; Härkönen, Pirkko L. // BMC Cancer;2008, Vol. 8, Special section p1 

    Background: Metastatic prostate cancer is associated with a high morbidity and mortality but the spreading mechanisms are still poorly understood. The aminobisphosphonate alendronate, used to reduce bone loss, has also been shown to inhibit the invasion and migration of prostate cancer cells in...

  • MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Liu, Y-N; Yin, J J; Abou-Kheir, W; Hynes, P G; Casey, O M; Fang, L; Yi, M; Stephens, R M; Seng, V; Sheppard-Tillman, H; Martin, P; Kelly, K // Oncogene;1/17/2013, Vol. 32 Issue 3, p296 

    Epithelial-mesenchymal transition (EMT) is a developmental program of signaling pathways that determine commitment to epithelial and mesenchymal phenotypes. In the prostate, EMT processes have been implicated in benign prostatic hyperplasia and prostate cancer progression. In a model of Pten-...

  • Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model. Boreddy, S R; Srivastava, S K // Oncogene;8/22/2013, Vol. 32 Issue 34, p3980 

    Deguelin is known to suppress the growth of cancer cells; however, its anti-metastatic effects have not been studied so far in any cancer model. In the present study, we aimed to evaluate the anti-metastatic potential of deguelin in vivo and in tumor growth factor-β1 (TGFβ1)-stimulated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics